October 1, 2021
Seigfreid Bingham is ecstatic to announce two new shareholders of the firm.
Jordan May
Jordan May, joined Seigfreid Bingham in 2014 as a summer associate and is a member of the litigation section. She primarily practices in the areas of […]
October 1, 2021
By Curry Sexton and Greg Whiston
The National Labor Relations Board’s (NLRB) General Counsel, Jennifer Abruzzo, issued a memo on Wednesday explaining why she believes intercollegiate athletes are employees of their respective institutions and are, therefore, entitled to statutory rights consistent with […]
September 29, 2021
Greg Whiston, shareholder, was named to the Up & Coming list for 2021 by Missouri Lawyers Media. This award recognizes young attorneys who are making a positive difference in the practice of law in Missouri and whose outstanding contributions […]
September 14, 2021
By Cody Weyhofen
On September 9, 2021, President Joe Biden announced
a series of sweeping vaccine mandates as part of his plan to combat the surging
COVID-19 Delta variant. In all, President Biden’s plan will impact a
significant portion of the American […]
By Cody Weyhofen
September 7, 2021
On August 28, 2021, Missouri joined the growing list
of states with legislation geared toward protecting employees who experience
domestic or sexual violence. Missouri’s new Victims Economic Safety and
Security Act (“VESSA”) requires public and private employers with at […]
September 7, 2021
By John Vering, Brenda Hamilton, and Mark Opara
Recent Developments on the Federal Level
On July 15,
2021, we alerted you to the fact that President Biden had issued an Executive
Order targeting non-compete agreements.
Click here for a link to that Client
Alert. […]
What Group Practices Need to Know About the Stark Law Final Rule’s Impact on Physician Compensation Plans, Effective Jan. 1, 2022 August 31, 2021By Lori Beam In the Stark Law Final Rule (Final Rule) issued in November 2020, the […]
August 31, 2021By John Vering, John Neyens, Shannon Johnson and Mark Opara
Recent Developments
There has been a flood of recent developments with
regard to Covid vaccines. First, the FDA
has given full approval to the Pfizer Covid-19 vaccine with indications that
full […]